Markt geschlossen -
Andere Börsenplätze
|
Nachbörslich 00:10:42 | |||
16,64 USD | +8,19 % | 16,84 | +1,17 % |
Kurzporträt
Mitarbeiterzahl: 155
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 01.11.18 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01.09.20 |
Charles York
DFI | Director of Finance/CFO | 47 | 01.02.21 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 01.10.22 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 01.05.23 |
Jaa Roberson
HRO | Human Resources Officer | - | 13.09.21 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 01.05.23 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 17.08.21 |
Natalie Holles
BRD | Director/Board Member | 51 | 01.02.21 |
John A. Josey
BRD | Director/Board Member | 63 | 01.09.20 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01.09.20 |
Director/Board Member | 37 | 01.12.19 | |
Director/Board Member | 48 | 01.03.21 | |
William Grossman
BRD | Director/Board Member | 54 | 17.01. |
Garry Nicholson
CHM | Chairman | 69 | 12.09.22 |
Habib Dable
BRD | Director/Board Member | 54 | 17.01. |
Dan Becker
BRD | Director/Board Member | 49 | 01.12.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 87 377 163 | 70 019 780 ( 80,14 %) | 0 | 80,14 % |
Unternehmenskontakt
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+13,97 % | 1,34 Mrd. | |
+3,13 % | 42,11 Mrd. | |
+48,83 % | 40,08 Mrd. | |
+8,49 % | 40 Mrd. | |
-10,82 % | 26,87 Mrd. | |
+8,26 % | 24,58 Mrd. | |
-23,69 % | 18,44 Mrd. | |
+1,58 % | 11,94 Mrd. | |
+32,83 % | 11,66 Mrd. | |
+6,63 % | 11,01 Mrd. |
- Börse
- Aktien
- A3CQ56 Aktie
- Unternehmen Day One Biopharmaceuticals, Inc.